| [1] |
Weetman AP.Graves' disease.N Engl J Med,2000,343(17):1236-1248. |
| [2] |
Pappa A,Lawson JM,Calder V,et al.T cells and fibroblasts in affected extraoculas muscles in early and late thyroid associated ophthalmopathy.Br J Ophthalmol,2000,84(5):517-522. |
| [3] |
李险峰,段练,陆克义,等.甲状腺功能亢进突眼患者99mTc-奥曲肽显像一例.放射学实践,2005,20(5):465-466. |
| [4] |
段炼,李险峰,陆克义,等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用.中华眼科杂志,2006(12. ). |
| [5] |
Moncayo R,Baldissera I,Decristoforo C,et al.Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatestatin analog 111In-octreotide.Thyroid,1997,7(1):21-29. |
| [6] |
Burggasser G,Hurtl I,Hauff W,et al.Orbital seintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.J Nucl Med,2003,44(10):1547-1555. |
| [7] |
Kainz H,Bale R,Donnemiller E,et al.Image fusion analysis of 99mTc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy:the importance of the lacrimal gland.Eur J Nucl Med Mol Imaging,2003,30(8):1155-1159. |
| [8] |
Krassas GE,Doumas A,Kaltsas T,et al.Somatestatin receptor scintigraphy before and after treatment with somatestatin analogues in patients with thyroid eye disease.Thyroid,1999,9(1):47-52. |
| [9] |
Galuska L,Leovey A,Szucs-Farkas Z,et al.SPECT using 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy:a comparison with the results from MRI.Nucl Med Commun,2002,23(12):1211-1216. |